. Author manuscript; available in PMC: 2016 Jun 1.

Published in final edited form as: Pharmacol Biochem Behav. 2015 Apr 8;133:111–121. doi: 10.1016/j.pbb.2015.03.021

Table 4.

Percent of females in each estrous stage (Pro=proestrus; Pro/Est=intermediate between proestrus and estrus; Est=estrus; Diest=diestrus day 1 or day 2) immediately after the pre-chronic and post-chronic tests.

Treatment Group (n)	Pre-chronic Test				Post-chronic Test
Treatment Group (n)	Pro	Pro/Est	Est	Diest	Pro	Pro/Est	Est	Diest
Sham-GDX
Vehicle (12)	25	16.7	16.7	41.6	8.3	16.7	25	50
THC (12)	16.7	25	0	58.3	16.7	16.7	25	41.6
GDX + 0
Vehicle (12)				100				100
THC (12)				100				100
GDX + P4
Vehicle (10)	10			90				100
THC (10)				100				100
GDX + E2
Vehicle (11)		18.2	81.8			18.2	81.8
THC (12)		8.3	91.7		8.3	25	66.7
GDX + E2/P4
Vehicle (12)		25	75			16.7	83.3
THC (12)		8.3	91.7		8.3	8.3	83.3